NCT00794495View on ClinicalTrials.gov

Preference for Clarinex Tablets vs. Zyrtec Tablets in Patients With Allergies (P03181)

PHASE4CompletedINTERVENTIONAL
Enrollment

122

Participants

Timeline

Start Date

December 31, 2002

Primary Completion Date

July 31, 2003

Study Completion Date

July 31, 2003

Conditions
Seasonal Allergic RhinitisPerennial Allergic Rhinitis
Interventions
DRUG

Desloratadine 5 mg (Clarinex)

Clarinex 5 mg daily x 7 days

DRUG

Cetirizine (Zyrtec)

Zyrtec 10 mg daily x 7 days

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00794495 - Preference for Clarinex Tablets vs. Zyrtec Tablets in Patients With Allergies (P03181) | Biotech Hunter | Biotech Hunter